Register for OBR daily


IMS_White_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CBMG $22.99 3.2600 +16.52%
NKTR $11.82 1.2700 +12.04%
SGEN $36.90 1.7000 +4.83%
EXEL $4.19 0.1600 +3.97%
MDVN $76.72 2.4900 +3.35%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

GALT $5.69 -0.4500 -7.33%
TGTX $7.37 -0.5400 -6.83%
IMNP $3.80 -0.2400 -5.94%
CTIC $2.44 -0.1500 -5.79%
EPZM $29.64 -1.6800 -5.36%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | Next > | Last >>

RJ Reynolds Vows to Fight $23.6B in Damages

(Washington Post/Associated Press) July 20, 2014 - The nation’s No. 2 cigarette maker is vowing to fight a jury verdict of $23.6 billion in punitive damages in a lawsuit filed by the widow of a longtime smoker who died of lung cancer.
read article (free registration required) 



Aduro BioTech Receives Breakthrough Therapy Designation from FDA for Innovative Pancreatic Cancer Combination Immunotherapy

(MarketWatch) July 21, 2014 - Aduro BioTech, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for its pancreatic cancer combination treatment that consists of its CRS-207 and GVAX Pancreas immunotherapies.
read article 



Allergan to Cut 1,500 Jobs as It Fights Valeant Hostile Bid

(Financial Times) July 21, 2014 - Allergan is to cut its global workforce by 13 per cent as part of a restructuring plan designed to save $475m next year, as the Botox maker steps up efforts to resist a $53bn hostile takeover by Valeant.
read article (free registration required) 



CMS Launches Next Phase of New Quality Improvement Program

(CMS.gov) July 18, 2014 - The Centers for Medicare & Medicaid Services (CMS) today awarded additional contracts as part of a restructuring the Quality Improvement Organization (QIO) Program to create a new approach to improve care for beneficiaries, families and caregivers.
read press release 



Americans Unsure How to Determine Quality of Doctors, Poll Finds

(FoxNews.com/Associated Press) July 21, 2014 - Americans consider insurance and a good bedside manner in choosing a doctor, but will that doctor provide high-quality care? A new poll shows that people don't know how to determine that.
read article 



Opinion: Where Is The Value In Health Care?

(Forbes/The Apothecary) July 21, 2014 - It seems that everywhere you look “value-based purchasing” (or value-based care) is hailed as the savior of U.S. health care. With it, comes the promise of a system that pays for quality rather than volume.
read article 



HIV Diagnosis Rate Fell by Third in U.S. Over Decade, Study Finds

(Washington Post/Associated Post) July 19, 2014 - The rate of HIV infections diagnosed in the United States each year fell by one-third over the past decade, a government study finds. Experts celebrated it as hopeful news that the country’s AIDS epidemic may be slowing.
read article (free registration required) 



U.S. Medicare Program Scales Back Hospice Drugs Restrictions

(Reuters) July 18, 2014 - The Obama administration on Friday backed down on restrictions of private insurance coverage for hospice drugs under Medicare, saying the regulations were preventing some terminally ill patients from having access to medicine.
read article 



Ignyta Announces Initiation of STARTRK-1 Global Phase I/II Clinical Trial of RXDX-101

(Ignyta) July 21, 2014 - Ignyta, Inc. today announced the multicenter initiation of the company’s global Phase I/II clinical trial of RXDX-101, its proprietary oral tyrosine kinase inhibitor targeting multiple solid tumor indications.
read corporate press release 



Newman's Notes: Inside the Ondansetron Black Box

(MedPage Today) July 20, 2014 - For years, we've used ondansetron (tradename Zofran). It's been around for about two decades now and there's been a whole lot of talk recently about a black box warning that the FDA put on it.
read article (free registration required) 



First Study Worldwide to Show Higher Concentration of Trace Elements in Bone Cancer

(MedUni Vienna [Austria]) July 21, 2014 - In a study that is the only one of its kind worldwide, researchers from the MedUni Vienna, the Vienna Technical University and the Ludwig Boltzmann Institute have investigated the distribution of trace elements in the tissue of bone tumours. The result: tumour tissue contains higher concentrations of trace elements.
read press release 



Singapore Scientists Discover Genetic Cause of Common Breast Tumours in Women

(SingHealth [Singapore]) July 21, 2014 - A multi-disciplinary team of scientists from the National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, and Singapore General Hospital have made a seminal breakthrough in understanding the molecular basis of fibroadenoma, one of the most common breast tumours diagnosed in women.
read press release 



Combined eNose and Sputum Hypermethylation Tests May Help Detect Lung Cancer

(Medscape Medical News/Reuters Health) July 21, 2014 - A combination of two non-invasive tests can detect a wide range of lung cancers, a new study suggests.
read article (free registration required) 



Yale Cancer Center Study Finds Low Oxygen Environment Helps Tumors Silence Critical Genes

(Yale Cancer Center) July 18, 2014 - A study led by Yale Cancer Center may provide clues to how some aggressive cancers turn off, or silence, genes critical to suppressing tumors.
read press release 



Yale Cancer Center Researchers Identify Possible Target for Immunotherapy in Early-Stage Breast Cancer

(Yale Cancer Center) July 17, 2014 – Yale Cancer Center researchers used a new molecular analysis tool to accurately detect the level of an important target for immunotherapy in early-stage breast cancers.
read press release 



HIV Said Cleared in Two Bone Marrow Transplant Patients

(Bloomberg) July 18, 2014 - Two cancer patients who were also infected with HIV went through bone marrow transplants and may no longer have the AIDS-causing virus, according to Australian doctors.
read article 



HPV Test Better Than Pap for Assessing Cervical Cancer Risk: Study

(Reuters Health) July 18, 2014 - Testing for human papillomavirus (HPV) may be the best way to know whether a woman is at risk of developing cervical cancer in the near future, according to a new study.
read article 



NIH Study Finds Negative HPV Screening Test Result Is a Better Predictor of Low Cervical Cancer Risk Than a Negative Pap Test

(NCI) July 18, 2014 - Based on a study that included more than 1 million women, investigators at the National Institutes of Health have determined that a negative test for human papillomavirus (HPV) infection compared to a negative Pap test provides greater safety, or assurance, against future risk of cervical cancer.
read press release 



AIDS Researcher Joep Lange Confirmed Among Dead in Malaysia Jet Shoot-Down

(Washington Post) July 17, 2014 - Members of the international HIV research community are reeling from the news that many of their own, including world-renowned AIDS researcher Joep Lange, perished when Malaysia Airlines Flight 17 was shot down Thursday over eastern Ukraine.
read article (free registration required) 



Amgen Reports Positive Phase 3 Results For Thyroid Drug AMG 416

(FinanzNachrichten/AFX News) July 17, 2014 - Amgen announced that a Phase 3 study evaluating AMG 416 for the treatment of secondary hyperparathyroidism or SHPT in patients with chronic kidney disease or CKD, receiving hemodialysis, met its primary and all secondary endpoints.
read article 



Lab Directors Send Letter to Obama Administration Opposing FDA Regulation of LDTs

(GenomeWeb Daily News) July 17, 2014 - Laboratory directors from more than 20 hospitals, academic health centers, and clinical laboratories are asking the Obama Administration not to allow the US Food and Drug Administration to regulate laboratory-developed tests.
read article (free registration required) 



FDA Committee to Discuss Adverse Effects of Testosterone Products

(Reuters) July 17, 2014 - The U.S. Food and Drug Administration has called an advisory committee meeting on Sept. 17, to discuss the adverse cardiovascular outcomes with the usage of testosterone replacement therapy.
read article 



AbbVie Clinches $54 Billion Deal For Shire in Huge Inversion to Cut Taxes

(New York Times/DealBook) July 18, 2014 - The pharmaceutical giant AbbVie agreed on Friday to buy its European rival Shire for around $54 billion in the biggest takeover deal so far this year.
read article 



Mark Soloway, MD, Internationally Recognized Leader in Urologic Oncology, Joins Memorial Cancer Institute to Start New Division

(PRWeb) July 17, 2014 - Dr. Mark Soloway, who has been appointed Chief of Urologic Oncology at Memorial Cancer Institute, will lead a new division focused on the care of bladder, prostate and kidney cancers, while also establishing a research program.
read press release 



Huntsman Cancer Institute Receives Funding to Establish a National Clinical Trials Network Site

(HCI/U of U) July 17, 2014 - A team of physician-researchers from Huntsman Cancer Institute (HCI) at the University of Utah (U of U) will receive nearly $3.6 million over the next five years in a cooperative agreement with the National Institutes of Health (NIH) to establish a Network Lead Academic Participating Site (NLAPS).
read press release